Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -39.19
- Piotroski Score 1.00
- Grade N/A
- Symbol (BBLG)
- Company Bone Biologics Corporation
- Price $1.30
- Changes Percentage (0%)
- Change -$0
- Day Low $1.26
- Day High $1.34
- Year High $10.56
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $19.88
- Trailing P/E Ratio 0.08
- Forward P/E Ratio 0.08
- P/E Growth 0.08
- Net Income $-8,948,731
Income Statement
Quarterly
Annual
Latest News of BBLG
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
BBLG Stock Price | Bone Biologics Corp. Stock Quote (U.S.: Nasdaq) | MarketWatch
Bone Biologics Corp. is a medical device company specializing in bone regeneration for spinal fusion. Their product, Nell-1, is an osteostimulative protein that enhances bone growth. Founded in 2004, ...
By MarketWatch | 3 months ago
